Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis.

04/09/2021 - 14:29

Aleksandra Kowalczyk, Agata Paneth, Damian Trojanowski, Piotr Paneth, Jolanta Zakrzewska-Czerwińska and Paweł Stączek International Journal of Molecular Sciences 2021, 22(8), 3881

Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis.

MAIN RESEARCH AREAS

Molecular biotechnology

In particular, new biological materials, new biocatalysts, and new regulatory molecules.

New materials

In particular, new bio-compatible polymers and bioconjugates.

Applied computational technologies

In particular, computer simulations and computational tools for the prediction of properties, structure, and dynamics of molecular and macromolecular systems.

PARTNERS

Strategic Partner

Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis.

MAIN RESEARCH AREAS

Molecular biotechnology

New materials

Applied computational technologies

PARTNERS

Strategic Partner

Max Planck Institute

Industrial Partners

SiA Pietrucha Sp. z o.o.

Grupa Maspex sp. z o.o sp. k

Adamed Pharma S.A.

International Centre for Research on Innovative Bio-based Materials